What is the CDSCO Single Window Portal? The National Single Window System (NSWS) is the Government of India’s unified digital platform for business approvals. For medical devices, CDSCO has been migrating several services to this portal since January 2024. It aims to provide a single interface for submitting applications, tracking status, and obtaining approvals instead […]
CDSCO Single Window Portal (NSWS) – Complete Overview Read More »
New Delhi — Importers seeking to bring medical devices into India must file Form MD-16 through the CDSCO online portal. The application is required under the Medical Devices Rules, 2017, to obtain a valid import license. The process applies to devices across all risk classes. Form MD-16 serves as the official application for an import
Form MD-16 Guide: Apply for Medical Device Import License Read More »
India’s CDSCO test license for medical devices has emerged as one of the most critical regulatory tools for exporters in 2026, as U.S. healthcare companies race to source high-quality, cost-effective medical equipment from Indian manufacturers. With CDSCO registration, medical device export compliance, India medical device regulations, Form MD-16 test license, and SUGAM portal submissions trending
The FDA detains or refuses thousands of medical device shipments at U.S. ports every year. Most of these disruptions — and the six-figure losses that often follow — are entirely preventable. In my 15+ years guiding international manufacturers and U.S. distributors through FDA import compliance, I’ve seen the same patterns repeat. Companies invest heavily in
The Indian pharmaceutical sector is experiencing a massive hiring surge. If you are a 2025 or 2026 batch graduate with a background in Pharmacy (B.Pharm/M.Pharm), Life Sciences (B.Sc/M.Sc), or Biotechnology, top multinational conglomerates are actively opening entry-level pipelines across India. Apart from the ongoing Biocon drive, several other market giants have activated their freshers recruitment
The Paradigm Shift in Global Market Access For years, the playbook for commercializing a medical device was predictable: secure a US FDA 510(k) clearance or an EU CE mark, and then leverage those approvals to gain entry into secondary global markets. Today, that linear path is gone. The convergence of tightening clinical requirements in Europe,
Indian medical device manufacturers are rapidly expanding into international markets. From surgical instruments and diagnostic kits to hospital equipment and disposable medical products, global demand for Indian-made healthcare products continues to grow. However, many exporters face delays because they are unaware of one critical requirement: embassy legalization of CDSCO documents. For Indian manufacturers planning to
Single Digital Platform Delivers Faster Approvals, Lower Costs, and Greater Transparency for Global Manufacturers NEW DELHI / NEW YORK — As India’s medical device market surges past $20 billion in 2026, the National Single Window System (NSWS) has emerged as one of the most powerful tools for foreign companies seeking regulatory approvals. The platform, developed
Essential Roadmap for American Companies Entering India’s Growing MedTech Market NEW DELHI — India’s medical device market is projected to cross $20 billion in 2026, making it one of the most attractive destinations for U.S. manufacturers. However, importing any medical device — from simple bandages to high-risk implants — requires a valid CDSCO Import License.
CDSCO Draft Amendments and FDA QMSR Lead Major Developments for Global Manufacturers NEW DELHI / WASHINGTON — The medical device regulatory landscape continues to evolve rapidly in 2026. India’s CDSCO has proposed significant amendments to the Medical Devices Rules, while the U.S. FDA has fully implemented its Quality Management System Regulation (QMSR). These updates affect
Medical Device Regulatory Updates May 2026: Key Changes in India & USA Read More »
